about
The hidden side of unstable DNA repeats: Mutagenesis at a distanceSelection and characterization of RNAs that relieve transcriptional interference in Escherichia coli.Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents.Targeting c-Myb expression in human disease.Selective Preference of Parallel DNA Triplexes Is Due to the Disruption of Hoogsteen Hydrogen Bonds Caused by the Severe Nonisostericity between the G*GC and T*AT Triplets.Parallel purine-pyrimidine-purine triplex: experimental evidence for existence.Extension of DNA triple helix formation to a neighbouring (AT)n site.Kinetic studies on the formation of acridine-linked DNA triple helices.Comparison of antiparallel A.AT and T.AT triplets within an alternate strand DNA triple helixDNA sequence specificity of a naphthylquinoline triple helix-binding ligand.Recognition of GC base pairs by triplex forming oligonucleotides containing nucleosides derived from 2-aminopyridine.Formation of DNA triple helices incorporating blocks of G.GC and T.AT triplets using short acridine-linked oligonucleotides.Polyamine-linked oligonucleotides for DNA triple helix formation.Effect of unmodified triple helix-forming oligodeoxyribonucleotide targeted to human multidrug-resistance gene mdr1 in MDR cancer cells.DNA triple-helix formation on nucleosome-bound poly(dA).poly(dT) tracts.Self-assembling of cytosine nucleoside into triply-bound dimers in acid media. A comprehensive evaluation of proton-bound pyrimidine nucleosides by electrospray tandem mass spectrometry, X-rays diffractometry, and theoretical calculations.Base-pair interactions in the gas-phase proton-bonded complexes of C+G and C+GC.From Bioengineering to CRISPR/Cas9 - A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting.
P2860
Q27027501-A464DE02-6C9C-4E0A-A3F7-3323C0513951Q32063455-D216F439-1DE9-4E16-878B-AAE85A712234Q34300807-C0DF2F8B-BAA6-4ECD-A173-E8A91BE19F6DQ35095153-9385BB1A-1DA2-4CBA-86EF-264E9FD53C16Q35968626-A7130703-689D-45D6-B725-F21A6691A3EDQ38294215-A76D2D1D-6C80-4B6D-A91C-20FEE92D701EQ38298628-5E6E5643-30CA-4F6F-B682-293C1C22F57BQ38299855-16347121-DADC-45D6-9220-38A02958D6EBQ38304267-FC43A179-3C6B-4C1A-A86E-B02527EDFA5AQ38351754-2BFB2FAB-0395-4AEB-8605-5F9217E5A459Q39721929-B43E80A4-FCC8-47F2-A824-DFDD56821FE3Q40399991-16C445B5-9947-4DF8-8264-6D453E940006Q40412730-4AB57638-493C-4B5B-95AC-526B6C4240DCQ41436576-335CC07E-5746-4C9C-810B-6784DAB1D6FCQ42962006-94F9A927-C5AF-494C-86BD-631D1F1553F4Q44758127-518784FF-0190-4125-BAC2-5902D9F28CB7Q46829808-64B2384D-E020-424E-9B95-25EA16C26EC0Q49495147-BBE3DE4D-38C8-4FBB-9E04-91AA83DC8D74
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Human therapeutics based on triple helix technology.
@ast
Human therapeutics based on triple helix technology.
@en
type
label
Human therapeutics based on triple helix technology.
@ast
Human therapeutics based on triple helix technology.
@en
prefLabel
Human therapeutics based on triple helix technology.
@ast
Human therapeutics based on triple helix technology.
@en
P1476
Human therapeutics based on triple helix technology.
@en
P2093
P304
P356
10.1016/0167-7799(92)90195-2
P577
1992-04-01T00:00:00Z